Evidence map›Paper›PMID 33475511›Full record

ArticleJMIR cancer2021

Cardiovascular Assessment Tool for Breast Cancer Survivors and Oncology Providers: Usability Study.

Kathryn E Weaver, Heidi D Klepin, Brian J Wells, Emily V Dressler, Karen M Winkfield, Zanetta S Lamar, Tiffany P Avery, Nicholas M Pajewski, W Gregory Hundley, Aimee Johnson and 3 more

Open access · goldAbstract read
In one paragraph

Article in JMIR cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. A Systematic Review of Cardiovascular Health Among Cancer Survivors.International journal of environmental research and public health · 2025
    Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Kathryn E WeaverDepartment of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, NC, United States.ORCID https://orcid.org/0000-0001-9006-4064
Heidi D KlepinSection on Hematology-Oncology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, United States.ORCID https://orcid.org/0000-0002-6262-1123
Brian J WellsDepartment of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, NC, United States.ORCID https://orcid.org/0000-0001-7310-6525
Emily V DresslerDepartment of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, NC, United States.ORCID https://orcid.org/0000-0002-6054-7839
Karen M WinkfieldDepartment of Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, NC, United States.ORCID https://orcid.org/0000-0002-4996-8093
Zanetta S LamarSection on Hematology-Oncology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, United States.ORCID https://orcid.org/0000-0002-0647-3963
Tiffany P AverySection on Hematology-Oncology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, United States.ORCID https://orcid.org/0000-0001-7658-2519
Nicholas M PajewskiDepartment of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, NC, United States.ORCID https://orcid.org/0000-0002-4447-6196
W Gregory HundleySection on Cardiology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, United States.ORCID https://orcid.org/0000-0002-2433-8853
Aimee JohnsonDepartment of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, NC, United States.ORCID https://orcid.org/0000-0002-8301-8294
Eleanor C DavidsonDepartment of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, NC, United States.ORCID https://orcid.org/0000-0002-7199-1855
Marcelo LopeteguiInstituto de Ciencias e Innovación en Medicina, Facultad de Medicina Clínica Alemana, Universidad del Desarrollo, Santiago, Chile.ORCID https://orcid.org/0000-0001-6007-144X
Randi E ForakerInstitute for Informatics, Washington University in St Louis School of Medicine, St Louis, MO, United States.ORCID https://orcid.org/0000-0001-9255-9394
Wake Forest University · USUniversidad del Desarrollo · CLWashington University in St. Louis · US

Funding

Wake Forest NCORP Research BaseUG1CA189824 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Emily Van Meter Dressler, GLENN J LESSER · 2014 to 2026
$57.9M
Tumor Tissue CoreP30CA012197 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Ruben A. Mesa · 1985 to 2026
$55.4M
Wake Forest Clinical and Translational Science AwardUL1TR001420 · NCATS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ARD, JAMY D, FOLEY, KRISTIE L · 2015 to 2023
$32.3M
Extending Automated Heart Health Assessment (AH-HA) for Cancer Survivors to Expand Provider and Patient Reach and Promote SustainabilityR01CA226078 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI RANDI E FORAKER, Kathryn Elizabeth Weaver · 2018 to 2026
$3.3M
NCATS NIH HHS UL1 TR001420NCI NIH HHS P30 CA012197NCI NIH HHS R01 CA226078NCI NIH HHS UG1 CA189824
6 · The paper itself

Abstract

backgroundCardiovascular health is of increasing concern to breast cancer survivors and their health care providers, as many survivors are more likely to die from cardiovascular disease than cancer. Implementing clinical decision support tools to address cardiovascular risk factor awareness in the oncology setting may enhance survivors' attainment or maintenance of cardiovascular health.

objectiveWe sought to evaluate survivors' awareness of cardiovascular risk factors and examine the usability of a novel electronic health record enabled cardiovascular health tool from the perspective of both breast cancer survivors and oncology providers.

methodsBreast cancer survivors (n=49) recruited from a survivorship clinic interacted with the cardiovascular health tool and completed pre and posttool assessments about cardiovascular health knowledge and perceptions of the tool. Oncologists, physician assistants, and nurse practitioners (n=20) who provide care to survivors also viewed the cardiovascular health tool and completed assessments of perceived usability and acceptability.

resultsEnrolled breast cancer survivors (84% White race, 4% Hispanic ethnicity) had been diagnosed 10.8 years ago (SD 6.0) with American Joint Committee on Cancer stage 0, I, or II (45/49, 92%). Prior to viewing the tool, 65% of survivors (32/49) reported not knowing their level for one or more cardiovascular health factors (range 0-4). On average, only 45% (range 0%-86%) of survivors' known cardiovascular health factors were at an ideal level. More than 50% of survivors had ideal smoking status (45/48, 94%) or blood glucose level (29/45, 64%); meanwhile, less than 50% had ideal blood pressure (12/49, 24%), body mass index (12/49, 24%), cholesterol level (17/35, 49%), diet (7/49, 14%), and physical activity (10/49. 20%). More than 90% of survivors thought the tool was easy to understand (46/47, 98%), improved their understanding (43/47, 91%), and was helpful (45/47, 96%); overall, 94% (44/47 survivors) liked the tool. A majority of survivors (44/47, 94%) thought oncologists should discuss cardiovascular health during survivorship care. Most (12/20, 60%) oncology providers (female: 12/20, 60%; physicians: 14/20, 70%) had been practicing for more than 5 years. Most providers agreed the tool provided useful information (18/20, 90%), would help their effectiveness (18/20, 90%), was easy to use (20/20, 100%), and presented information in a useful format (19/20, 95%); and 85% of providers (17/20) reported they would use the tool most or all of the time when providing survivorship care.

conclusionsThese usability data demonstrate acceptability of a cardiovascular health clinical decision support tool in oncology practices. Oncology providers and breast cancer survivors would likely value the integration of such apps in survivorship care. By increasing awareness and communication regarding cardiovascular health, electronic health record-enabled tools may improve survivorship care delivery for breast cancer and ultimately patient outcomes.

Indexed as

breast cancercancer survivorscardiovascular diseasesclinical decision supportelectronic health recordsusability testing

Identifiers

PMID33475511
PMCPMC7861995
OpenAlexW3121932028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.